The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer
Abstract
Purpose: We previously identified three genes, HOXB13, IL17BR and CHDH, and the HOXB13:IL17BR ratio index in particular, that strongly predicted clinical outcome in breast cancer patients receiving tamoxifen monotherapy. Confirmation in larger independent patient cohorts was needed to fully validate their clinical utility. Patients and Methods: Expression of HOXB13, IL17BR, CHDH, estrogen receptor (ER) and progesterone receptor (PR) were quantified by real-time polymerase chain reaction in 852 formalin-fixed, paraffin-embedded primary breast cancers from 566 untreated and 286 tamoxifen-treated breast cancer patients. Gene expression and clinical variables were analyzed for association with relapse-free survival (RFS) by Cox proportional hazards regression models. Results: ER and PR mRNA measurements were in close agreement with immunohistochemistry. In the entire cohort, expression of HOXB13 was associated with shorter RFS (P = .008), and expression of IL17BR and CHDH was associated with longer RFS (P < .0001 for IL17BR and P = .0002 for CHDH). In ER+ patients, the HOXB13:IL17BR index predicted clinical outcome independently of treatment, but more strongly in node-negative patients. In multivariate analysis of the ER+ node-negative subgroup including age, PR status, tumor size, S phase fraction, and tamoxifen treatment, the two-gene index remained a significant predictor of RFS (hazard ratio = 3.9; 95% CI, 1.5 to 10.3; P = .007). Conclusion: This tumor bank study demonstrated HOXB13:IL17BR index is a strong independent prognostic factor for ER+ node-negative patients irrespective of tamoxifen therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
Allred, D. C., Harvey, J. M., Berardo, M. D., & Gm, C. (1998) · PubMed · Cited by 2,143
Self-citationHarvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056
Self-citationSotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi326 · Cited by 1,127
Ellis, M. J., Coop, A., Singh, B., Mauriac, L., Llombert-Cussac, A., Jänicke, F., Miller, W. R., Evans, D. B., Dugan, M., Brady, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3808 · Cited by 1,060
Ma, X.-J., Wang, Z., Ryan, P. D., Isakoff, S. J., Barmettler, A., Fuller, A., Muir, B., Mohapatra, G., Salunga, R., Tuggle, J. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.015 · Cited by 954
Self-citationChang, J. C., Wooten, E. C., Tsimelzon, A., Hilsenbeck, S. G., Gutierrez, M. C., Elledge, R., Mohsin, S., Osborne, C. K., Chamness, G. C., Allred, D. C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14023-8 · Cited by 875
Self-citationModel-based clustering and data transformations for gene expression data
Yeung, K. Y., Fraley, C., Murua, A., Raftery, A. E., & Ruzzo, W. L. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.10.977 · Cited by 869
Partial Proportional Odds Models for Ordinal Response Variables
Peterson, B., & Harrell, F. E. (1990) · Applied Statistics · doi:10.2307/2347760 · Cited by 813
Osborne, C. K., Bardou, V., Hopp, T. A., Chamness, G. C., Hilsenbeck, S. G., Fuqua, S. A. W., Wong, J., Allred, D. C., Clark, G. M., & Schiff, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.353 · Cited by 786
Self-citationBardou, V.-J., Arpino, G., Elledge, R. M., Osborne, C. K., & Clark, G. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.099 · Cited by 752
Self-citationGene expression predictors of breast cancer outcomes
Huang, E., Cheng, S. H., Dressman, H., Pittman, J., Tsou, M. H., Horng, C. F., Bild, A., Iversen, E. S., Liao, M., Chen, C. M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13308-9 · Cited by 627
Measurement of Gene Expression in Archival Paraffin-Embedded Tissues
Cronin, M., Pho, M., Dutta, D., Stephans, J. C., Shak, S., Kiefer, M. C., Esteban, J. M., & Baker, J. B. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63093-3 · Cited by 551
MCLUST: Software for Model-Based Cluster Analysis
Fraley, C., & Raftery, A. E. (1999) · Journal of Classification · doi:10.1007/s003579900058 · Cited by 485
Chromogenic in Situ Hybridization
Tanner, M., Gancberg, D., Di Leo, A., Larsimont, D., Rouas, G., Piccart, M. J., & Isola, J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64785-2 · Cited by 383
Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling
Jansen, M. P. H. M., Foekens, J. A., van Staveren, I. L., Dirkzwager-Kiel, M. M., Ritstier, K., Look, M. P., Meijer-van Gelder, M. E., Sieuwerts, A. M., Portengen, H., Dorssers, L. C. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.145 · Cited by 340
Mohsin, S. K., Weiss, H., Havighurst, T., Clark, G. M., Berardo, M., Roanh, L. D., To, T. V., Zho, Q., Love, R. R., & Allred, D. C. (2004) · Modern Pathology · doi:10.1038/modpathol.3800229 · Cited by 290
Self-citationDowsett, M., Harper-Wynne, C. L., Boeddinghaus, I., Salter, J., Hills, M., Dixon, M., Ebbs, S. R., Gui, G. P., Sacks, N., & Smith, I. E. (2001) · PubMed · Cited by 172
Goetz, M. P., Suman, V. J., Ingle, J. N., Nibbe, A. M., Visscher, D. W., Reynolds, C. A., Lingle, W. L., Erlander, M., Ma, X.-J., Sgroi, D. C., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1263 · Cited by 170
Self-citationFaraggi, D., & Simon, R. M. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19961030)15:20<2203::aid-sim357>3.0.co;2-g · Cited by 150
The Explained Variation in Proportional Hazards Regression
SCHEMPER, M. (1990) · Biometrika · doi:10.1093/biomet/77.1.216 · Cited by 129
Limits of Predictive Models Using Microarray Data for Breast Cancer Clinical Treatment Outcome
Reid, J. F., Lusa, L., Cecco, L. D., Coradini, D., Veneroni, S., Daidone, M. G., Gariboldi, M., & Pierotti, M. A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji153 · Cited by 116
川上, 雅., & 佐治, 重. (2005) · Mebio oncology · Cited by 112
Breast Cancer Clinical Practice Guidelines in Oncology
Carlson, R. W., Anderson, B. O., Burstein, H. J., Cox, C. E., Edge, S. B., Farrar, W. B., Goldstein, L. J., Gradishar, W. J., Hayes, D. F., Hudis, C. A., et al. (2005) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2005.0015 · Cited by 77
Yamashita, T., Tazawa, S., Zhao, Y.-W., Katayama, H., Kato, Y., 西脇, 邦., Yokohama, Y., & Ishikawa, M. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.4.931 · Cited by 76
Evi27 encodes a novel membrane protein with homology to the IL17 receptor
Tian, E., Sawyer, J. R., Largaespada, D. A., Jenkins, N. A., Copeland, N. G., & Shaughnessy, J. D. (2000) · Oncogene · doi:10.1038/sj.onc.1203577 · Cited by 67
Investigating Time Dependence in Cox's Proportional Hazards Model
Pettitt, A. N., & Daud, I. (1990) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.2307/2347382 · Cited by 58
Altered HOX Gene Expression in Human Skin and Breast Cancer Cells
Svingen, T., & Tonissen, K. F. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.5.441 · Cited by 57
Re: Limits of Predictive Models Using Microarray Data for Breast Cancer Clinical Treatment Outcome
Jansen, M. P. H. M., Foekens, J. A., Klijn, J. G. M., & Berns, E. M. J. J. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji433 · Cited by 9
Cited by
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Gene-Expression Signatures in Breast Cancer
Sotiriou, C., & Pusztai, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801289 · Cited by 1,485
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0021 · Cited by 806
Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials
Sparano, J. A., & Paik, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1068 · Cited by 617
Enabling personalized cancer medicine through analysis of gene-expression patterns
van 't Veer, L. J., & Bernards, R. (2008) · Nature · doi:10.1038/nature06915 · Cited by 554
Metadata
- Authors
- Ma, X.-J., Hilsenbeck, S. G., Wang, W., Ding, L., Sgroi, D. C., Bender, R. A., Osborne, C. K., Allred, D. C., & Erlander, M. G.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-10-01
- Volume
- 24
- Issue
- 28
- Pages
- 4611-4619
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2107333022
- Cited by
- 252
- References
- 36
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.